Has Kristyn Thorpe received payments from drug or device companies?

Yes. Drug and device makers reported $1,847 in general payments to Kristyn Thorpe across 85 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kristyn Thorpe did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kristyn Thorpe come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kristyn Thorpe

Family · Lees Summit, MONPI 1770128688

Payments from drug & device makers

$1,847in general payments, 2019–2025

Across 85 payments — averaging $21.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$400
Johnson & Johnson$239
QOL Medical, LLC$156
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$155
Takeda Pharmaceuticals U.S.A., Inc.$134
Merck$133
plus $631 from 13 others

What the payments were for

Food & beverage$1,847100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	22	$400
Johnson & Johnson	7	$239
QOL Medical, LLC	6	$156
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	12	$155
Takeda Pharmaceuticals U.S.A., Inc.	6	$134
Merck	7	$133
Lilly USA, LLC	4	$125
Genentech USA, Inc.	2	$119
Sanofi	2	$60
Ironwood Pharmaceuticals, Inc	2	$55
Organon	3	$53
Ardelyx, Inc.	2	$46
Fresenius Kabi USA, LLC	2	$42
Pfizer	2	$32
Bristol Myers Squibb	2	$31
Daiichi Sankyo Inc.	1	$22
Gilead	1	$18
Intercept Pharmaceuticals, Inc.	1	$14
Ferring Pharmaceuticals Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Xofluza$113

How this compares

$1,847 in reported general payments places this provider in the 75th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
XifaxanRifaximin	23	$68,989
CreonLipase/Protease/Amylase	18	$50,721
ZenpepLipase/Protease/Amylase	13	$46,825
LinzessLinaclotide	41	$41,889
PentasaMesalamine	14	$19,683
Mesalamine	20	$10,899
ErythromycinErythromycin Base	20	$7,672
Colestipol Hcl	45	$4,036
Omeprazole	186	$3,295
Famotidine	157	$2,781
Pantoprazole Sodium	157	$2,687
Azathioprine	18	$2,504
Dicyclomine Hcl	80	$2,364
Ondansetron OdtOndansetron	11	$456
Sucralfate	22	$440

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AbbVieCreon, Linzess	$400	$92,61059 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan	$155	$68,98923 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,812 family providers in Missouri.

Other family in Lees Summit

Tamera WolfLees Summit$215K
Crystal DavisonLees Summit$16K
Christine HuntLees Summit$12K
Connie SpencerSaint Joseph$320K
Shayla SandersKansas City$306K
Tiffany ArnoldFestus$177K
Tiffany NelsonSedalia$164K
Chelsey BeckerSaint Peters$104K
Carey PattonDes Peres$94K
Marcy MarkesColumbia$92K

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →